ALNY – Alnylam Pharmaceuticals – dropped 10% today (Monday, December 7, 2015). It closed at $97.72. On Friday, December 4th, 2015, ALNY closed at $109.
On Sunday, ALNY announced positive Phase 1/2 trial of one of its drugs.
The sell-off could be attributed to overall sell-off in biotech sector.
If ALNY does not stop at $97 level then we could possibly see $88 before it finds its next support.
Chart of ALNY is shown below.
To find out about companies like ALNY (Alnylam Pharmaceuticals) that are releasing positive trial data but still selling-off, it is important to be a subscriber of options trading services provided by Financial Markets Wizard.